Over the past decade, Branhamella catarrhalis has emerged as an import
ant human pathogen. The bacterium is a common cause of otitis media in
children and of lower respiratory tract infections in adults with chr
onic obstructive pulmonary disease. B. catarrhalis is exclusively a hu
man pathogen. It colonizes the respiratory tract of a small proportion
of adults and a larger proportion of children. Studies involving rest
riction enzyme analysis of genomic DNA show that colonization is a dyn
amic process, with the human host eliminating and acquiring new strain
s frequently. The surface of B. catarrhalis contains outer membrane pr
oteins, lipooligosaccharide, and pili. The genes which encode several
outer membrane proteins have been cloned, and some of these proteins a
re being studied as potential vaccine antigens. Analysis of the immune
response has been limited by the lack of an adequate animal model of
B. catarrhalis infection. New information regarding outer membrane str
ucture should guide studies of the human immune response to B. catarrh
alis. Immunoassays which specifically detect antibodies to determinant
s exposed on the bacterial surface will elucidate the most relevant im
mune response. The recognition of B. catarrhalis as an important human
pathogen has stimulated research on the epidemiology and surface stru
ctures of the bacterium. Future studies to under-stand the mechanisms
of infection and to elucidate the human immune response to infection h
old promise of developing new methods to treat and prevent infections
caused by B. catarrhalis.